J.P. Morgan Maintains Overweight on Danaher

J.P. Morgan is out with its report today on Danaher DHR, maintaining Overweight. In a note to clients, J.P. Morgan writes, "2Q results at DHR were solid, though the organic growth miss and mixed segment performance was not enough in the context of recent upside prints – as is customary with expectations at DHR, there is typically little room for any fundamental questions post-quarter. Our estimates (which included BEC) are unchanged, though the stock thesis is intact, with shares offering a combination of near term safety through macro volatility as well as upside potential in the form of BEC execution in 2012 and beyond. We remain OW on this basis." J.P. Morgan maintains a $60 PT on DHR. Shares of DHR closed Thursday at $52.43, down 1.28% from Wednesday's close.